Calls and Puts for Income Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Calls and Puts for Income

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jerome who wrote (188)	4/15/2007 4:18:42 PM
From: im a survivor	Read Replies (1) of 5891

Agree. But even if it does fall that far, that would be the adjusted cost basis anyway, around $7.75 - $8 The news I have been reading has been both positive and negative...some are saying the drug will get fda approval on the 15th, while others say they will have to do further studies. I look at it like this. Stock is all over the place but was at $5 and ran to I think $25. Currently at $17.75 and you can sell the may $10's for around $2bucks. That is a very nice premium and stock would have to fall alot(it could) to be assigned, but if assigned at $10, adjusted cost basis would be around $7.75 - $8. So, the question is do I want to take very nice premiums in exchange for possibly having to own DNDN for about $7.75. Then write CC's against it if assigned, and if the PPS and premiums allow for CC's. Anybody else gonna play this? I'm still curious on Bridges play I commented on earlier as it seems to guarantee a profit, assuming stock stays within a certain range and I believe the range was from $10 - $30...would like to hear more opinions on it...TIA....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next